Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 5/2015

01-05-2015 | Original Article – Cancer Research

Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility

Authors: P. Mota, H. C. Silva, M. J. Soares, A. Pego, M. Loureiro, C. Robalo Cordeiro, F. J. Regateiro

Published in: Journal of Cancer Research and Clinical Oncology | Issue 5/2015

Login to get access

Abstract

Objectives

Tobacco exposure remains the main etiologic factor for lung cancer (LC). Interactions between environment and individual genetic profile are particularly important for this disease. The aim of this study was to evaluate the contribution of CYP1A1*2A, CYP1A1*2C, CYP2D6*4, GSTP1, GSTM1, GSTT1 and NAT2 polymorphisms for the susceptibility to LC in a Portuguese population considering their demographic and clinical characteristics.

Materials and methods

A total of 200 LC and 247 controls subjects from the Centre of Portugal were studied. Clinical and demographic characteristics were collected from clinical files and by individual questionnaires. Polymorphisms of CYP1A1*2A, CYP1A1*2C, CYP2D6*4, GSTP1, GSTM1, GSTT1 and NAT2 were genotyped using PCR–RFLP, PCR multiplex, ARMS and real time.

Results

Gender, family history of cancer, smoke cessation and alcohol consumption were independent risk factors (p < 0.05). Associations found between phases I and II genes and LC population reveal a sex dependent distribution. Logistic regression analysis demonstrates that enhanced activation by CYPs, associated by reduced or loss of function of phase II enzymes, can lead to a greater risk. GSTP1 and NAT2 polymorphisms studied have a significant contribution for the histological tumour types and the presence of metastases, at time of diagnosis, respectively, when males with smoking habits were considered.

Conclusion

Multiple interactions between environment and individual characteristics are clearly associated to this disease. Variants of the detoxification genes may act synergistically contributing to this disease and modifying the risk posed by smoking and sex. The GSTT1*0 and GSTP1 (Ile462Val) might contribute to the malignant phenotype through different mechanisms.
Literature
go back to reference Benedetti A, Parent ME, Siemiatycki J (2006) Consumption of alcoholic beverages and risk of lung cancer: results from two case-control studies in Montreal, Canada. Cancer Causes Control 17:469–480CrossRefPubMed Benedetti A, Parent ME, Siemiatycki J (2006) Consumption of alcoholic beverages and risk of lung cancer: results from two case-control studies in Montreal, Canada. Cancer Causes Control 17:469–480CrossRefPubMed
go back to reference Bertram J, Rogers A (1981) Recovery of bronchial epithelium on stopping smoking. Br Med J 283:1567–1569CrossRef Bertram J, Rogers A (1981) Recovery of bronchial epithelium on stopping smoking. Br Med J 283:1567–1569CrossRef
go back to reference Board P, Menon D (2013) Glutathione transferases, regulators of cellular metabolism and physiology. Biochim Biophys Acta 1830:3267–3288CrossRefPubMed Board P, Menon D (2013) Glutathione transferases, regulators of cellular metabolism and physiology. Biochim Biophys Acta 1830:3267–3288CrossRefPubMed
go back to reference Božina N, Bradamante V, Lovrić M (2009) Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk. Arh Hig Rada Toksikol 60:217–242PubMed Božina N, Bradamante V, Lovrić M (2009) Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk. Arh Hig Rada Toksikol 60:217–242PubMed
go back to reference Carlsten C, Saggo GS, Frodshem AJ, Burke W, Higgins JP (2008) Glutathione S-Transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167:759–774CrossRefPubMed Carlsten C, Saggo GS, Frodshem AJ, Burke W, Higgins JP (2008) Glutathione S-Transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167:759–774CrossRefPubMed
go back to reference Chen Z, Li Z, Niu X, Yu Y, Lu S (2011) The effect of CYP1A1 polymorphism on the risk of lung cancer: a global meta-analysis based on 71 case-control studies. Mutagenesis 26:437–446CrossRefPubMed Chen Z, Li Z, Niu X, Yu Y, Lu S (2011) The effect of CYP1A1 polymorphism on the risk of lung cancer: a global meta-analysis based on 71 case-control studies. Mutagenesis 26:437–446CrossRefPubMed
go back to reference Christensen PM, Gotzsche PC, Brosen K (1997) The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis. Eur J Clin Pharmacol 51:389–393CrossRefPubMed Christensen PM, Gotzsche PC, Brosen K (1997) The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis. Eur J Clin Pharmacol 51:389–393CrossRefPubMed
go back to reference Cohen S, Paré P, Man S, Sin D (2007) The growing burden of chronic obstructive pulmonary disease and lung cancer in women. Am J Respir Crit Care Med 176:113–120CrossRef Cohen S, Paré P, Man S, Sin D (2007) The growing burden of chronic obstructive pulmonary disease and lung cancer in women. Am J Respir Crit Care Med 176:113–120CrossRef
go back to reference Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403CrossRefPubMed Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403CrossRefPubMed
go back to reference Freudenheim JL, Ritz J, Smith-Warner SA, Albanes D, Bandera EV, van den Brandt P, Colditz G, Feskanich D, Goldbohm RA, Harnack L, Miller A, Rimm E, Rohan T, Sellers T, Virtamo J, Willett W, Hunter D (2005) Alcohol consumption and risk of lung cancer: a pooled analysis of cohort studies. Am J Clin Nutr 82:657–667PubMed Freudenheim JL, Ritz J, Smith-Warner SA, Albanes D, Bandera EV, van den Brandt P, Colditz G, Feskanich D, Goldbohm RA, Harnack L, Miller A, Rimm E, Rohan T, Sellers T, Virtamo J, Willett W, Hunter D (2005) Alcohol consumption and risk of lung cancer: a pooled analysis of cohort studies. Am J Clin Nutr 82:657–667PubMed
go back to reference Gao CM, Takezaki T, Wu JZ, Li ZY, Liu YT, Li SP et al (2002) Glutathione S-Transferase M1 (GSTM1) and GSTT1 genotype, smoking, consumption of alcohol and tea and risk of esophageal and stomach cancers: a case control study of a high incidence area in Jiangsu Province, China. Cancer Lett 188:95–102CrossRefPubMed Gao CM, Takezaki T, Wu JZ, Li ZY, Liu YT, Li SP et al (2002) Glutathione S-Transferase M1 (GSTM1) and GSTT1 genotype, smoking, consumption of alcohol and tea and risk of esophageal and stomach cancers: a case control study of a high incidence area in Jiangsu Province, China. Cancer Lett 188:95–102CrossRefPubMed
go back to reference Gough AC, Miles JS, Spurr NK, Moss JE, Gaedigk A, Eichelbeum M, Wolf CR (1990) Identification of the primary gene defect at the cytochrome P450 CYP2D locus. Reprinted from Nature, Macmillan Magazines Ltd 347:773–776 Gough AC, Miles JS, Spurr NK, Moss JE, Gaedigk A, Eichelbeum M, Wolf CR (1990) Identification of the primary gene defect at the cytochrome P450 CYP2D locus. Reprinted from Nature, Macmillan Magazines Ltd 347:773–776
go back to reference Gross M, Kruisselbrink T, Anderson K, Lang N, McGovern P, Delongchamp R, Kadlubar F (1999) Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population. Cancer Epidemiol Biomark Prev 8:683–692 Gross M, Kruisselbrink T, Anderson K, Lang N, McGovern P, Delongchamp R, Kadlubar F (1999) Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population. Cancer Epidemiol Biomark Prev 8:683–692
go back to reference Hayashi S, Watanabe J, Nakachi K, Kawajiri K (1991) Genetic linkage of lung cancer –associated Msp1 polymorphism with aminoacid replacement in the heme binding region of the human cytochrome P450 1A1 gene. J Biochem 110:407–411PubMed Hayashi S, Watanabe J, Nakachi K, Kawajiri K (1991) Genetic linkage of lung cancer –associated Msp1 polymorphism with aminoacid replacement in the heme binding region of the human cytochrome P450 1A1 gene. J Biochem 110:407–411PubMed
go back to reference Hayes J, Strange R (2000a) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61:154–166CrossRefPubMed Hayes J, Strange R (2000a) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61:154–166CrossRefPubMed
go back to reference Hayes J, Strange R (2000b) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61:154–166CrossRefPubMed Hayes J, Strange R (2000b) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61:154–166CrossRefPubMed
go back to reference Hecht SS (2002) Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet oncol 3:461–469CrossRefPubMed Hecht SS (2002) Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet oncol 3:461–469CrossRefPubMed
go back to reference Holley S, Fryer A, Haycock J, Grubb A, Strange R, Hoban P (2007) Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis. Carcinogenesis 28(11):2268–2273CrossRefPubMed Holley S, Fryer A, Haycock J, Grubb A, Strange R, Hoban P (2007) Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis. Carcinogenesis 28(11):2268–2273CrossRefPubMed
go back to reference Josephy P (2010) Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology. Hum Genomics Proteomics 2010:876940 Josephy P (2010) Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology. Hum Genomics Proteomics 2010:876940
go back to reference Kawajiri K, Nakachi K, Imai K et al (1990a) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450 1A1 gene. FEBS Lett 263:131–133CrossRefPubMed Kawajiri K, Nakachi K, Imai K et al (1990a) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450 1A1 gene. FEBS Lett 263:131–133CrossRefPubMed
go back to reference Kawajiri K, Nakachi K, Imai K et al (1990b) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett 263:131–133CrossRefPubMed Kawajiri K, Nakachi K, Imai K et al (1990b) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett 263:131–133CrossRefPubMed
go back to reference Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S (1993) The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol 14:77–87CrossRefPubMed Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S (1993) The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol 14:77–87CrossRefPubMed
go back to reference Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K (1991) Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 51:5177–5180PubMed Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K (1991) Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 51:5177–5180PubMed
go back to reference North C, Christiani D (2013) Women and lung cancer: what is new? Semin Thorac Surg 25:87–94CrossRef North C, Christiani D (2013) Women and lung cancer: what is new? Semin Thorac Surg 25:87–94CrossRef
go back to reference Pallis A, Syrigos K (2013) Lung cancer in never smokers: disease characteristics and risk factors. Crit Rev Oncol/Hematol 88:494–503CrossRef Pallis A, Syrigos K (2013) Lung cancer in never smokers: disease characteristics and risk factors. Crit Rev Oncol/Hematol 88:494–503CrossRef
go back to reference Pool-Zobel B, Veeriah S, Böhmer FD (2005) Modulation of xenobiotic metabolizing enzymes by anticarcinogens—focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat Res 591(1–2):74–92CrossRefPubMed Pool-Zobel B, Veeriah S, Böhmer FD (2005) Modulation of xenobiotic metabolizing enzymes by anticarcinogens—focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat Res 591(1–2):74–92CrossRefPubMed
go back to reference Ritchie K, Henderson C, Wang X, Vassieva O, Carrie D et al (2007) Glutathione transferase plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane. Cancer Res 67:9248–9257 Ritchie K, Henderson C, Wang X, Vassieva O, Carrie D et al (2007) Glutathione transferase plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane. Cancer Res 67:9248–9257
go back to reference Rostami-Hodjegan A, Lennard MS, Woods HF, Tucker GT (1998) Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson’s disease. Pharmacogenetics 8:227–238CrossRefPubMed Rostami-Hodjegan A, Lennard MS, Woods HF, Tucker GT (1998) Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson’s disease. Pharmacogenetics 8:227–238CrossRefPubMed
go back to reference Saxena A, Dhillon VS, Shahid M, Khalil HS et al (2012) GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients. Exp Ther Med 4(6):1097–1103 PMCID: PMC3494109PubMedCentralPubMed Saxena A, Dhillon VS, Shahid M, Khalil HS et al (2012) GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients. Exp Ther Med 4(6):1097–1103 PMCID: PMC3494109PubMedCentralPubMed
go back to reference Smith C, Wadelius M, Gough A, Harrisson D, Wolf C, Rane A (1997) A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid. J Med Genet 34:758–760CrossRefPubMedCentralPubMed Smith C, Wadelius M, Gough A, Harrisson D, Wolf C, Rane A (1997) A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid. J Med Genet 34:758–760CrossRefPubMedCentralPubMed
go back to reference Sreejal Syamola V, Hariharan S et al (2005) Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet 50:618–627CrossRef Sreejal Syamola V, Hariharan S et al (2005) Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet 50:618–627CrossRef
go back to reference Sweeney C, Nazar-Stewart V, Stapleton P, Eaton D, Vaughan T (2003) Glutathione S-transferase M1, T1 and P1 polymorphisms and survival among lung cancer patients. Cancer Epidemiol Biomark Prev 12:527–533 Sweeney C, Nazar-Stewart V, Stapleton P, Eaton D, Vaughan T (2003) Glutathione S-transferase M1, T1 and P1 polymorphisms and survival among lung cancer patients. Cancer Epidemiol Biomark Prev 12:527–533
go back to reference Tyczynski J, Bray F, Parkin DM (2003) Lung cancer in Europe in 2000: epidemiology, prevention and early detection. Lancet oncol 4:45–55CrossRefPubMed Tyczynski J, Bray F, Parkin DM (2003) Lung cancer in Europe in 2000: epidemiology, prevention and early detection. Lancet oncol 4:45–55CrossRefPubMed
go back to reference Wright CM, Larsen JE, Colosimo ML, Barr JJ, Chen L, McLachlan RE, Yang IA, Bowman RV, Fong KM (2010) Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in non small cell lung cancer. Eur Respir J 35:152–159CrossRefPubMed Wright CM, Larsen JE, Colosimo ML, Barr JJ, Chen L, McLachlan RE, Yang IA, Bowman RV, Fong KM (2010) Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in non small cell lung cancer. Eur Respir J 35:152–159CrossRefPubMed
go back to reference Wu J, Sin D (2011) Improved patient outcome with smoking cessation: when is it too late? Int J COPD 6:259–267 Wu J, Sin D (2011) Improved patient outcome with smoking cessation: when is it too late? Int J COPD 6:259–267
go back to reference Zanger U, Schwab M (2013) Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities and impact of genetic variation. Pharmacol Ther 138:103–141CrossRefPubMed Zanger U, Schwab M (2013) Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities and impact of genetic variation. Pharmacol Ther 138:103–141CrossRefPubMed
Metadata
Title
Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility
Authors
P. Mota
H. C. Silva
M. J. Soares
A. Pego
M. Loureiro
C. Robalo Cordeiro
F. J. Regateiro
Publication date
01-05-2015
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 5/2015
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-014-1868-z

Other articles of this Issue 5/2015

Journal of Cancer Research and Clinical Oncology 5/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.